Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.64 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.58 |
| ▸ | FNTA | P49354 | 1/20 | 0.58 |
| ▸ | FNTB | P49356 | 1/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.58 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6533249 | 0.90 | SLC15A1 (0.66) | SLC7A5SLC15A1ALPIPKMPTGS1 | |
| Tyrosine SCHEMBL28244030 | 0.84 | SLC7A5 (0.89) | SLC7A5SLC15A1FNTAFNTBALPI | |
| SCHEMBL15295143 | 0.84 | SLC7A5 (0.70) | SLC7A5SLC15A1FNTAFNTBALPI | |
| Tyrosine SCHEMBL1003558 | 0.84 | SLC7A5 (0.89) | SLC7A5SLC15A1FNTAFNTBALPI | |
| Tyrosine SCHEMBL5699043 | 0.84 | SLC7A5 (0.89) | SLC7A5SLC15A1FNTAFNTBALPI | |
| Tyrosine SCHEMBL133206 | 0.84 | SLC7A5 (0.89) | SLC7A5SLC15A1FNTAFNTBALPI | |
| Tyrosine SCHEMBL27641183 | 0.84 | SLC7A5 (0.89) | SLC7A5SLC15A1FNTAFNTBALPI | |
| Tyrosine SCHEMBL18222727 | 0.84 | SLC7A5 (0.89) | SLC7A5SLC15A1FNTAFNTBALPI | |
| Tyrosine SCHEMBL5699039 | 0.84 | SLC7A5 (0.89) | SLC7A5SLC15A1FNTAFNTBALPI | |
| SCHEMBL21466078 | 0.84 | SLC15A1 (0.64) | SLC7A5SLC15A1ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240148721-A1 | DISCRETE PEG CONSTRUCTS | AUDAX PRIVATE DEBT LLC, AS AGENT | 2024-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148721-A1 | DISCRETE PEG CONSTRUCTS | MUC1, EGFR, LNPEP | SLC7A5 1842/4885SLC15A1 3039/4885FNTA 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.